Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 214 participants.

Also called NCT07246629

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 214 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07246629
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07246629. Randomized; triple masking; primary purpose prevention. Start 2027-01 (anticipated); primary completion 2028-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
Condition
Subarachnoid Hemorrhage
Intervention (Drug)
Normal Saline
Intervention (Drug)
Nicardipine
Lead sponsor
Wake Forest University Health Sciences (class: other)

Record details

Record id
cardio:ct-nct07246629
Content hash
58a63447fac794f97281a0faec01e45ef2faa81377026e679deb3cc03494c645